Full text is available at the source.
Creation of a Novel Humanized Dystrophic Mouse Model of Duchenne Muscular Dystrophy and Application of a CRISPR/Cas9 Gene Editing Therapy
New Human-Like Mouse Model for Duchenne Muscular Dystrophy and Testing of a Gene Editing Treatment
AI simplified
Abstract
A novel dystrophic mouse model was developed by deleting exon 45 in the human DMD gene using CRISPR/Cas9.
- Mutations in the DMD gene disrupt the reading frame, leading to Duchenne muscular dystrophy.
- Therapeutic strategies, including exon skipping and CRISPR/Cas9, aim to restore the DMD reading frame.
- The new mouse model allows for testing of these therapeutic strategies in a living organism.
- Application of CRISPR/Cas9 targeting exons 45-55 in the model may restore dystrophin production.
AI simplified